PineBridge Investments’s New York Times NYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
+3,698
New +$285K ﹤0.01% 513
2026
Q1
Sell
-14,713
Closed -$1.02M 554
2025
Q4
$1.02M Sell
14,713
-1,742
-11% -$108K 0.01% 417
2025
Q3
$945K Sell
16,455
-5,673
-26% -$324K 0.01% 431
2025
Q2
$1.24M Sell
22,128
-16,148
-42% -$856K 0.01% 454
2025
Q1
$1.9M Sell
38,276
-16,321
-30% -$820K 0.02% 421
2024
Q4
$2.84M Buy
54,597
+17,225
+46% +$940K 0.02% 448
2024
Q3
$2.08M Buy
37,372
+29,927
+402% +$1.61M 0.02% 464
2024
Q2
$381K Sell
7,445
-1,546
-17% -$72.7K ﹤0.01% 503
2024
Q1
$389K Buy
+8,991
New +$409K ﹤0.01% 528
2023
Q3
Sell
-997
Closed -$39.3K 892
2023
Q2
$39.3K Buy
+997
New +$37.9K ﹤0.01% 686
2021
Q1
Sell
-1,848
Closed -$96K 690
2020
Q4
$96K Buy
+1,848
New +$82.1K ﹤0.01% 566

Other funds holding NYT

PineBridge Investments's NYT Position: Q2 2026 in Review

PineBridge Investments opened a new position in New York Times (NYT) in Q2 2026: 3,698 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #513 among its holdings. This is a return to the name: PineBridge Investments previously reported a position in NYT as recently as Q4 2025.

PineBridge Investments first reported a position in NYT in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.84M in Q4 2024. 632 funds tracked by Wall St. Rank hold NYT as of Q2 2026.

  • PineBridge Investments held 3,698 shares of New York Times worth $259K as of Q2 2026.
  • New York Times was a new PineBridge Investments position in Q2 2026.
  • New York Times made up ﹤0.01% of PineBridge Investments's portfolio in Q2 2026, its #513 holding.
  • PineBridge Investments first reported a position in New York Times in Q4 2020 and has held it in 11 quarters since.
  • PineBridge Investments's New York Times position peaked at $2.84M in Q4 2024.
  • 632 funds tracked by Wall St. Rank held New York Times as of Q2 2026.

Based on PineBridge Investments's 13F filing for Q2 2026, filed 14 Aug 2026.